Evidence map›Paper›PMID 40848127›Full record

ArticleMikrochimica acta2025

An AND-gate DNA walker sensing microRNA and flap endonuclease 1.

Zuoling Zhang, Mengling Wang, Tingting Hu, Yijun Yuan, Yunlong Zhang, Qinxin Song, Chen Wang, Bingjie Zou

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zuoling ZhangKey Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, School of Pharmacy, China Pharmaceutical University, 210009, Nanjing, China.
Mengling WangKey Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, School of Pharmacy, China Pharmaceutical University, 210009, Nanjing, China.
Tingting HuKey Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, School of Pharmacy, China Pharmaceutical University, 210009, Nanjing, China.
Yijun YuanKey Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, School of Pharmacy, China Pharmaceutical University, 210009, Nanjing, China.
Yunlong ZhangKey Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, School of Pharmacy, China Pharmaceutical University, 210009, Nanjing, China.
Qinxin SongKey Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, School of Pharmacy, China Pharmaceutical University, 210009, Nanjing, China. songqinxin@cpu.edu.cn.
Chen WangKey Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, School of Pharmacy, China Pharmaceutical University, 210009, Nanjing, China. wangchen11459@126.com.
Bingjie ZouKey Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, School of Pharmacy, China Pharmaceutical University, 210009, Nanjing, China.ORCID 0000-0003-1056-9156

Funding

Jiangsu Province Key R&D Program Social Development Project No. BE2023843National Innovation and Entrepreneurship Training Program for Undergraduate No.3322400176National Natural Science Foundation of China No. 82173780National Natural Science Foundation of China No. 82404581Natural Science Foundation of Jiangsu Province No. BK20241591
6 · The paper itself

Abstract

Precise and sensitive detection of cancer biomarkers is essential for early diagnosis and effective treatment. However, most existing sensing strategies rely on single targets, which may lack the specificity required for accurate disease diagnosis. To address this limitation, we propose an AND-gate logic DNA walker capable of simultaneously detecting two distinct types of biomarkers: miRNA-21 and flap endonuclease 1 (FEN1). This DNA walker employs a capture strand immobilized on AuNPs to bind miRNA-21, which then hybridizes with a fluorescent-tagged track strand to form a structure recognizable by FEN1. Upon FEN1 cleavage, fluorescence signals are released, enabling highly sensitive detection. The detection limits were 23.3 pM for miRNA-21 and 0.097 pg/μL for FEN1. The DNA walker demonstrates exceptional performance in intracellular in situ imaging of these biomarkers, offering a powerful tool for cancer diagnosis and investigation of disease mechanisms. This AND-gate DNA walker serves as a model for constructing multi-target detection systems with high specificity and sensitivity.

Indexed as

Biosensing TechniquesDNAFlap EndonucleasesMicroRNAsBiomarkers, TumorFluorescent DyesHumansLimit of DetectionMetal NanoparticlesBiomarkers, TumorDNAFEN1 protein, humanFlap EndonucleasesFluorescent DyesMicroRNAsMIRN21 microRNA, humanAuNPsBiosensorDNA walkerFEN1MicroRNA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.